Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 25Neoplasms 3Neoplasm Metastasis 3Stomach Neoplasms 1Sarcoma 1Osteitis Deformans 1Neoplastic Cells, Circulating 1Invasive Breast Cancer 1Head and Neck Neoplasms 1HER2-positive Advanced Breast Cancer 1HER2+ Metastatic Breast Cancer (MBC) 1HER2 Positive Metastatic Breast Cancer 1Esophageal Neoplasms 1Carcinoma 1Breast Neoplasms, Male 1Brain Neoplasms 1

Interventions

Capecitabine 2Vinorelbine 1Trastuzumab 1Lapatinib 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × HER2-positive Advanced Breast Cancer × Lapatinib × Clear all
NCT04185649 2019-12-04

The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Bio-Thera Solutions

Phase 3 Unknown
410 enrolled
Breast

HER2-positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡